Search results
Introducing ProteinMentor® a multi-attribute platform technology for the biopharma industry
NBC 10 - FOX 14 Monroe· 1 day agoProtein Dynamic Solutions this week launched its State-of-the-Art ProteinMentor® platform technology at the PEGS Boston Summit. ProteinMentor® consists of a Quantum Cascade ...
Earnings call: Nikon forecasts steady growth and sustainable focus By Investing.com
Investing.com· 6 days agoNikon (OTC:NINOY) Corporation (TYO: 7731) has released its financial results for the past fiscal...
West Greene students explore the microscopic world of nanotechnology
The Uniontown Herald Standard· 2 days agoHigh School are learning how small technologies can have a big impact on the world. According to...
Get the Facts: A look at economic claims made by both major presidential candidates
KSBW Salinas· 1 day agoRecent economic claims made by major presidential candidates have been put under the microscope,...
What's Going On With Palantir Technologies Stock Today? - Palantir Technologies (NYSE:PLTR)
Benzinga· 4 days agoLast week, Palantir Technologies reported strong Q1 results, beating revenue estimates and...
Colleges, police blame ‘outside agitators’ for campus protests. Experts say it’s not so simple
The Hill via AOL· 2 days agoAs the dust settles and the number of pro-Palestinian student encampments dwindle, claims of...
The Assassin’s Creed Heroes, Ranked From Worst To Best
Kotaku via Yahoo News· 1 day agoAssassin’s Creed Shadows is adding two new heroes to the pantheon of brave and stealthy killers that...
CMU walks a tightrope
The Daily Sentinel· 5 days agoThe Israel-Hamas war (and the protests it has sparked) have put free speech under a microscope as college campuses — and even the federal government — struggle to define when ...
EP4-induced mitochondrial localization and cell migration mediated by CALML6 in human oral squamous...
Nature· 5 days agoEP4 receptor enhances OSCC cell migration through increased Ca2+ signaling, linking to CALML6 and the CaMKK2 pathway. This process promotes mitochondrial function and metastasis, with CaMKK2 emerging as a potential target for OSCC treatment.
Akoya Biosciences (NASDAQ:AKYA) PT Lowered to $6.00
ETF DAILY NEWS· 3 days agoAkoya Biosciences (NASDAQ:AKYA – Get Free Report) had its target price lowered by equities researchers at BTIG Research from $9.00 to $6.00 in a report issued on Tuesday, Benzinga reports. BTIG ...
